Price $5.11 |
Market Cap
102.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.44
|
P/S
26.19
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-14.8K
|
FCF
-0.5
|
|
Op. Margin
-860.30%
|
Net Margin
-820.40%
|
ROE
-13.10%
|
ROI
-14.10%
|
|
ROA
-12.70%
|
EPS Growth
-87.40%
|
Current Ratio
53.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $7.23 | - | - | 9.93B | Strong Buy |
| Lifecore Biomedical Inc (LFCR) | $8.15 | - | - | 114.9M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $4.00 | - | - | 191M | Strong Buy |
| Kamada Ltd. (KMDA) | $4.78 | - | - | 207.1M | Strong Buy |
| Jounce Therapeutics Inc (JNCE) | $1.88 | - | - | 96.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
